| Literature DB >> 21535247 |
Nicolas Salomé1, Magdalena Taube, Emil Egecioglu, Caroline Hansson, Björn Stenström, Duan Chen, Daniel R Andersson, H Georg Kuhn, Claes Ohlsson, Suzanne L Dickson.
Abstract
Gastrectomy (Gsx) is associated with altered emotional function and a predisposition to depression/anxiety disorders. Here we investigated the effects of Gsx on emotional reactivity in rats and explored the underlying neurobiological mechanisms. Gsx- and sham-operated rats were exposed to behavioural tests that explore anxiety- and depression-like behaviour (open field, black and white box, elevated plus maze, social interaction, forced swim) as well as memory (object recognition). The potential neurobiological mechanisms underlying these differences were explored by measuring (i) turnover of candidate neurotransmitter systems in the nucleus accumbens, (ii) hippocampal neurogenesis by BrdU labelling or by analysis of candidate genes involved in neuronal growth and (iii) changes in mRNA expression of candidate genes in dissected hippocampal and amygdala tissue. Data from individual behavioural tests as well as from multivariate analysis revealed differing emotional reactivity between Gsx- and sham-operated rats. Gsx rats showed reduced emotional reactivity in a new environment and decreased depression-like behaviour. Accumbal serotonin and dopamine turnover were both reduced in Gsx rats. Gsx also led to a memory deficit, although hippocampal neurogenesis was unaffected. Of the many candidate genes studied by real-time RT-PCR, we highlight a Gsx-associated decrease in expression of Egr-1, a transcription factor linked to neural plasticity and cognition, in the hippocampus and amygdala. Thus, Gsx induces an alteration of emotional reactivity and a memory/cognitive deficit that is associated with reduced turnover of serotonin and dopamine in the nucleus accumbens and decreased expression of Egr-1 in the hippocampus and amygdala.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21535247 PMCID: PMC3110309 DOI: 10.1111/j.1460-9568.2011.07640.x
Source DB: PubMed Journal: Eur J Neurosci ISSN: 0953-816X Impact factor: 3.386
Gene targets and TaqMan assay identities (id) loaded on the Taq®Man Array
| Gene target | Gene name | Assay id |
|---|---|---|
| Endogenous controls | ||
| 18S | Eukaryotic 18S rRNA | Hs99999901_s1 |
| Actb | Actin, beta | Rn00667869_m1 |
| Gapdh | Glyceraldehyde-3-phosphate dehydrogenase | Rn99999916_s1 |
| Ppia | Peptidylprolyl isomerase A | Rn00690933_m1 |
| Rplp2 | Ribosomal protein, large P27 | Rn01479927_g1 |
| Transcriptor factor/signal transduction | ||
| Crebbp | CREB binding protein | Rn00591291_m1 |
| Egr1 | Early growth response 1 | Rn00561138_m1 |
| Map2k2 | Mitogen activated protein kinase kinase 2 | Rn00590971_m1 |
| Trh | Thyrotropin-releasing hormone | Rn00564880_m1 |
| Transporter/enzymatic activity | ||
| Gad1 | Glutamic acid decarboxylase 1 (67) | Rn00566593_m1 |
| Th | Tyrosine hydroxylase | Rn00562500_m1 |
| Slc1a2 | Glt1 solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Rn00568080_m1 |
| Slc6a3 | Dat1 solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | Rn00562224_m1 |
| Slc6a4 | 5HTT neurotransmitter transporter, serotonin | Rn00564737_m1 |
| Neural growth/differentiation | ||
| Bdnf | Brain-derived neurotrophic factor | Rn01484928_m1 |
| Ntrk2 | Neurotrophic tyrosine kinase, receptor, type 2 | Rn00820626_m1 |
| Ncam1 | Neural cell adhesion molecule 1 | Rn00580526_m1 |
| Ngfb | Nerve growth factor beta | Rn01533872_m1 |
| Receptor activity | ||
| Adipor1 | Adiponectin receptor 1 | Rn01114954_g1 |
| Cckbr | Cannabinoid receptor1 | Rn00565867_m1 |
| Drd3 | Dopamine receptor 3 | Rn00567568_m1 |
| Gabra1 | Gamma-aminobutyric acid A receptor, alpha1 | Rn00788315_m1 |
| Gabra3 | Gamma-aminobutyric acid A receptor, alpha3 | Rn00567055_m1 |
| Gabra4 | Gamma-aminobutyric acid A receptor, alpha4 | Rn00589846_m1 |
| Gabra5 | Gamma-aminobutyric acid A receptor, alpha5 | Rn00568803_m1 |
| Galr2 | Galanin receptor 2 | Rn01773918_m1 |
| Galr3 | Galanin receptor 3 | Rn02132531_s1 |
| Ghsr | Growth hormone secretagogue receptor | Rn00821417_m1 |
| Htr1a | 5-hydroxytryptamine (serotonin) receptor 1A | Rn00561409_s1 |
| Htr2c | 5-hydroxytryptamine (serotonin) receptor 2C | Rn00562748_m1 |
| Insr | Insulin receptor | Rn00567070_m1 |
| Lepr | Leptin receptor | Rn01433205_m1 |
Fig. 1Behavioural parameters of sham-operated (n=10) and Gsx rats (n=6) in the open field during the 10-min test period. Columns and bars represent mean ± SEM. *P <0.05.
Behavioural parameters of sham-operated (n=10) and Gsx rats (n=6) in the black and white box and elevated plus maze
| Sham | Gastrectomy | |
|---|---|---|
| Black and white box | ||
| Number of groomings | 2.6 ± 0.3 | 1.7 ± 0.2 |
| Time grooming (s) | 31.0 ± 6.2 | 16.7 ± 1.9 |
| Latency first white entry (s) | 2.6 ± 1.7 | 2.5 ± 0.9 |
| Time in white (s) | 23.5 ± 7.9 | 15.9 ± 5.2 |
| Transition number | 3.2 ± 0.8 | 2.0 ± 0.4 |
| Rearing number in white | 2.9 ± 1.1 | 1.5 ± 0.8 |
| Rearing number in black | 14.7 ± 1.7 | 13.2 ± 2.3 |
| Elevated plus maze | ||
| Closed arm entries | 4.9 ± 0.8 | 5.5 ± 0.8 |
| Total arm entries | 8.2 ± 1.0 | 6.0 ± 1.1 |
| Percentage open arm entries | 34.1 ± 4.5 | 24.3 ± 2.8 |
| Percentage time spent open arm | 10.1 ± 2.8 | 8.7 ± 2.8 |
| Percentage time spent central platform | 3.6 ± 1.3 | 7.0 ± 1.8 |
The test periods were 10 min in the black and white box and 5 min in the elevated plus maze. Values are expressed as mean ± SEM.
Fig. 2Behavioural parameters of sham-operated (n=10) and Gsx rats (n=6) in the forced swim test during (A) the three triads of the first day, (B) the 15 min of the first day and (C) the first 5 min of the 15 min pre-test session at the first day and during the test phase (5 min) on the second day. *P <0.05, ***P<0.001 Gsx vs. sham; ♦P<0.05, ♦♦♦P <0.001 when comparing day 1 and 2 for each surgical group.
Results from the discriminant analysis of sham-operated and Gsx rats in the four behavioural tests
| Percentage correct | ||||||
|---|---|---|---|---|---|---|
| Test | Sham | Gsx | Discriminating variables | Tolerance | ||
| Open field | 100 | 83.3 | Line crossings | 5.44 | 0.03 | 0.99 |
| Time grooming | 0.66 | 0.23 | 0.99 | |||
| Black and white box | 80.0 | 83.3 | Rearing white | 4.39 | 0.05 | 0.58 |
| Grooming time | 1.11 | 0.31 | 0.32 | |||
| Grooming latency | 1.10 | 0.31 | 0.39 | |||
| Grooming number | 0.42 | 0.42 | 0.39 | |||
| Elevated plus maze | 90.0 | 83.3 | Percentage time centre | 6.78 | 0.02 | 0.60 |
| Percentage entries open arm | 4.95 | 0.04 | 0.60 | |||
| Forced swim test | ||||||
| 1st day | 90.0 | 100 | Immobility (1st triad) | 11.11 | 0.01 | 0.55 |
| Struggling (2nd triad) | 2.57 | 0.13 | 0.58 | |||
| Struggling (3rd triad) | 0.62 | 0.44 | 0.91 | |||
| Struggling (total) | 0.02 | 0.87 | 0.57 | |||
| 2nd day | 100 | 83.3 | Swimming | 24.78 | 0.00 | 0.99 |
| Struggling | 1.21 | 0.29 | 0.99 | |||
For each test the percentage of correct classification of sham/Gsx animals is given. Within each test, variables were organized with the highest discriminating power first, as indicated by the F-value. The corresponding P-level was given for each F. The tolerance value is a measure of the redundancy of a variable with other variables in the same test (a higher tolerance indicates lower redundancy).
Principal components (multivariate) analysis of 11 variables obtained from the open field, black and white box, elevated plus maze and forced swim tests
| Test/variable | Factor 1 | Factor 2 | Factor 3 | Factor 4 |
|---|---|---|---|---|
| Open field | ||||
| Rearing number periphery | 0.85 | |||
| Line crossings | 0.81 | 0.41 | ||
| Grooming number | 0.69 | |||
| Black and white box | ||||
| Rearing number white | 0.40 | 0.73 | ||
| Grooming number | 0.54 | 0.54 | ||
| Elevated plus maze | ||||
| Rearing number closed arm | 0.83 | |||
| Percentage entries open arm | 0.46 | |||
| Percentage time centre | −0.61 | −0.59 | ||
| Forced swim test | ||||
| Immobility 1st triad | 0.89 | |||
| Struggling 2nd triad | 0.81 | |||
| Time swimming 2nd day | −0.88 | |||
| Percentage total variance | 27.25 | 20.82 | 16.29 | 12.23 |
The most significant factor loadings, higher than 0.4, are shown for each behavioural parameter.
Fig. 3Distribution of sham-operated/Gsx rats along the two first factors extracted with the principal components analysis. Factor 1 was represented by the horizontal axis and accounts for 27.25% of the total variance. Factor 2 was represented by the vertical axis and accounts for 20.82% of the total variance. This principal components analysis was based on the behavioural results obtained in the open field (number of rearings at the periphery, number of line crossings, number of groomings), the black and white box (number of rearings in the white compartment, number of groomings), the elevated plus maze (number of rearings in the closed arms, percentage of entries into the open arms, percentage of time spent in the central zone) and in the forced swim test (immobility during the first triad, struggling during the second triad, time spent swimming the second day).
Fig. 4Time spent exploring during the recognition trial of the object recognition test. Rats from the sham group spent more time exploring the new object whereas rats from the Gsx gruop spent the same time exploring the old and new object. Sham, n=9; Gsx group, n=5. ***P<0.001.
Comparison of cerebral serotonin (5-HT), 5-hydroxiindolacetic acid (5-HIAA), turnover of serotonin (TU 5-HT), dopamine, (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and turnover of dopamine (DOPAC/DA and HVA/DA) expressed in fmol/g of tissue between sham-operated (n=10) and Gsx rats (n=6)
| Prefrontal cortex | Nucleus accumbens | |||
|---|---|---|---|---|
| Sham | Gsx | Sham | Gsx | |
| 5-HT | 619.83 ± 29.28 | 686.26 ± 44.97 | 946.35 ± 36.69 | 948.06 ± 33.25 |
| 5-HIAA | 229.29 ± 12.19 | 211.80 ± 7.94 | 314.22 ± 14.01 | 281.02 ± 15.04 |
| 5-HIAA/5HT | 0.37 ± 0.02 | 0.312 ± 0.02 | 0.33 ± 0.01 | 0.29 ± 0.01* |
| DA | 402.73 ± 63.23 | 755.10 ± 313.03 | 3730.15 ± 160.49 | 3645.32 ± 551.23 |
| DOPAC | 357.18 ± 18.25 | 450.16 ± 71.89 | 913.07 ± 45.19 | 618.88 ± 167.26 |
| HVA | 47.52 ± 4.25 | 50.04 ± 14.31 | 155.45 ± 13.93 | 125.64 ± 18.81 |
| DOPAC/DA | 1.08 ± 0.21 | 0.91 ± 0.20 | 0.24 ± 0.01 | 0.15 ± 0.03* |
| HVA/DA | 0.12 ± 0.02 | 0.08 ± 0.01 | 0.04 ± 0.00 | 0.04 ± 0.00 |
Values are expressed as mean ± SEM. *P < 0.05.
Fig. 5Effects of Gsx on hippocampal mRNA expression of adipor1 (adiponectin receptor 1), insulin receptor (insr), Egr-1 (early growth response protein 1), Trh (thyrotropin-releasing hormone) and Galr3 (galanin receptor 3) in comparison with sham-operation. P<0.05 for all comparisons.